A pharmacoeconomic evaluation of aprepitant injection versus aprepitant capsules for the prevention of CINV caused by moderately and highly emetogenic chemotherapy. [PDF]
Chen Z +6 more
europepmc +1 more source
In Vivo Evaluation of Psoralen in a Copper Sulfate-Induced Chick (Gallus gallus domesticus) Emesis Model and In Silico Analysis of Its Interaction With D<sub>2</sub>, 5-HT<sub>3</sub> <sub>A</sub>, and Muscarinic Receptors. [PDF]
Chandra K +12 more
europepmc +1 more source
Comparative effectiveness and safety of ondansetron-based dual versus triple antiemetic regimens for chemotherapy-induced nausea and vomiting. [PDF]
Yu X +9 more
europepmc +1 more source
Optimising Non-operative Management of Inoperable Malignant Bowel Obstruction: A Clinical Review for Surgical Practice. [PDF]
Alkashty M, Kahka E, Hameed W, Eshra Y.
europepmc +1 more source
Revisiting the Role of Lorazepam as an Adjunct in the Management of Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis. [PDF]
Peng TR, Lin HH, Wu TW, Hsu CY.
europepmc +1 more source
Efficacy of Combined Ramosetron and Dexamethasone on Postoperative Recovery in Patients Undergoing General Anesthesia: A Multicenter Randomized Controlled Trial. [PDF]
Lee KS +7 more
europepmc +1 more source
Analysis of risk factors for postoperative vomiting following general anesthesia in total knee arthroplasty patients. [PDF]
Ge R, Yong Z, Xie XF, He T.
europepmc +1 more source
Effects of tegileridine versus sufentanil on postoperative nausea and vomiting in female patients undergoing laparoscopic cholecystectomy with a multimodal antiemetic approach based in Chengdu, China: protocol for a dual-centre randomised controlled trial. [PDF]
Wang X, Li Y, Yang J, Li X.
europepmc +1 more source
Efficacy of olanzapine for prophylaxis of delayed chemotherapy-induced nausea and vomiting in patients with breast cancer receiving dose-dense AC with a steroid-sparing regimen: a single-center pilot study. [PDF]
Tada M +6 more
europepmc +1 more source
Safety of Short-T erm Low-Dose Olanzapine in Patients with Cancer and Diabetes Receiving Cisplatin-Based Chemotherapy: A Retrospective TriNetX Cohort Study. [PDF]
Hayashi T +4 more
europepmc +1 more source

